Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL31214327 | 0.80 | — | — | |
| Acetic Acid SCHEMBL28221982 | 0.80 | — | — | |
| Acetic Acid SCHEMBL1674512 | 0.80 | FFAR3 (1.00) | — | |
| Acetic Acid SCHEMBL11142541 | 0.80 | FFAR3 (1.00) | — | |
| Acetic Acid SCHEMBL8742314 | 0.80 | FFAR3 (1.00) | — | |
| Acetic Acid SCHEMBL7472549 | 0.80 | — | — | |
| Acetic Acid SCHEMBL1330415 | 0.80 | — | — | |
| Acetic Acid SCHEMBL1331719 | 0.80 | — | — | |
| Acetic Acid SCHEMBL1331810 | 0.80 | — | — | |
| Acetic Acid SCHEMBL6788 | 0.80 | FFAR3 (1.00) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12180341-B2 | Collectors for flotation process | BASF SE (DE) | 2024-12-31 | — | — | US | disclosed |
| CN-114452397-B | Drug delivery vehicle and pharmaceutical formulation for co-delivering multiple therapeutic agents using the same | 复旦大学 | 2024-12-03 | — | — | CN | disclosed |
| CN-110167938-B | Novel amino-imidazopyridine derivatives as Janus kinase inhibitors and medical uses thereof | 阿基利昂有限公司 | 2024-06-14 | — | — | CN | disclosed |
| EP-3980189-B1 | COLLECTORS FOR FLOTATION PROCESS | BASF SE (DE) | 2023-08-09 | — | — | EP | disclosed |
| US-20220227936-A1 | COLLECTORS FOR FLOTATION PROCESS | BASF SE (DE) | 2022-07-21 | — | — | US | disclosed |
| EP-3980189-A1 | COLLECTORS FOR FLOTATION PROCESS | BASF SE (DE) | 2022-04-13 | — | — | EP | disclosed |
| CN-103249737-B | Borate as arginase inhibitor | 马尔斯公司 | 2016-06-08 | — | — | CN | disclosed |
| EP-1506969-B1 | Compounds with growth hormone releasing properties | HELSINN THERAPEUTICS US INC (US) | 2010-06-09 | — | — | EP | disclosed |
| EP-1506969-A1 | Compounds with growth hormone releasing properties | NOVO NORDISK A/S (DK) | 2005-02-16 | — | — | EP | disclosed |
| EP-1047709-B1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK AS (DK) | 2004-11-03 | — | — | EP | disclosed |
| EP-1047709-A1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK A/S (DK) | 2000-11-02 | — | — | EP | disclosed |
| WO-1999036431-A9 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK AS (DK) | 2000-07-27 | — | — | WO | disclosed |
| US-6083908-A | TREATING MEDICAL DISORDERS RESULTING FROM DEFICIENCY IN GROWTH HORMONE | NOVO NORDISK A/S (DK) | 2000-07-04 | — | — | US | disclosed |
| WO-1999036431-A1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK A/S (DK) | 1999-07-22 | — | — | WO | disclosed |